Literature DB >> 34073442

Glioma-Specific Diffusion Signature in Diffusion Kurtosis Imaging.

Johann-Martin Hempel1,2, Cornelia Brendle1,2, Sasan Darius Adib2,3, Felix Behling2,3,4, Ghazaleh Tabatabai2,4,5,6, Salvador Castaneda Vega2,7, Jens Schittenhelm2,6, Ulrike Ernemann1,2, Uwe Klose1.   

Abstract

PURPOSE: This study aimed to assess the relationship between mean kurtosis (MK) and mean diffusivity (MD) values from whole-brain diffusion kurtosis imaging (DKI) parametric maps in preoperative magnetic resonance (MR) images from 2016 World Health Organization Classification of Tumors of the Central Nervous System integrated glioma groups.
METHODS: Seventy-seven patients with histopathologically confirmed treatment-naïve glioma were retrospectively assessed between 1 August 2013 and 30 October 2017. The area on scatter plots with a specific combination of MK and MD values, not occurring in the healthy brain, was labeled, and the corresponding voxels were visualized on the fluid-attenuated inversion recovery (FLAIR) images. Reversely, the labeled voxels were compared to those of the manually segmented tumor volume, and the Dice similarity coefficient was used to investigate their spatial overlap.
RESULTS: A specific combination of MK and MD values in whole-brain DKI maps, visualized on a two-dimensional scatter plot, exclusively occurs in glioma tissue including the perifocal infiltrative zone and is absent in tissue of the normal brain or from other intracranial compartments.
CONCLUSIONS: A unique diffusion signature with a specific combination of MK and MD values from whole-brain DKI can identify diffuse glioma without any previous segmentation. This feature might influence artificial intelligence algorithms for automatic tumor segmentation and provide new aspects of tumor heterogeneity.

Entities:  

Keywords:  diffusion kurtosis imaging; diffusion signature; glioma; mean diffusivity; mean kurtosis; segmentation

Year:  2021        PMID: 34073442     DOI: 10.3390/jcm10112325

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  50 in total

1.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  J Clin Epidemiol       Date:  2008-04       Impact factor: 6.437

2.  cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas.

Authors:  Daniel J Brat; Kenneth Aldape; Howard Colman; Dominique Figrarella-Branger; Gregory N Fuller; Caterina Giannini; Eric C Holland; Robert B Jenkins; Bette Kleinschmidt-DeMasters; Takashi Komori; Johan M Kros; David N Louis; Catriona McLean; Arie Perry; Guido Reifenberger; Chitra Sarkar; Roger Stupp; Martin J van den Bent; Andreas von Deimling; Michael Weller
Journal:  Acta Neuropathol       Date:  2020-01-29       Impact factor: 17.088

3.  ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.

Authors:  David E Reuss; Felix Sahm; Daniel Schrimpf; Benedikt Wiestler; David Capper; Christian Koelsche; Leonille Schweizer; Andrey Korshunov; David T W Jones; Volker Hovestadt; Michel Mittelbronn; Jens Schittenhelm; Christel Herold-Mende; Andreas Unterberg; Michael Platten; Michael Weller; Wolfgang Wick; Stefan M Pfister; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2014-11-27       Impact factor: 17.088

Review 4.  Body diffusion kurtosis imaging: Basic principles, applications, and considerations for clinical practice.

Authors:  Andrew B Rosenkrantz; Anwar R Padhani; Thomas L Chenevert; Dow-Mu Koh; Frederik De Keyzer; Bachir Taouli; Denis Le Bihan
Journal:  J Magn Reson Imaging       Date:  2015-06-26       Impact factor: 4.813

5.  MGMT gene silencing and benefit from temozolomide in glioblastoma.

Authors:  Monika E Hegi; Annie-Claire Diserens; Thierry Gorlia; Marie-France Hamou; Nicolas de Tribolet; Michael Weller; Johan M Kros; Johannes A Hainfellner; Warren Mason; Luigi Mariani; Jacoline E C Bromberg; Peter Hau; René O Mirimanoff; J Gregory Cairncross; Robert C Janzer; Roger Stupp
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

6.  Cerebral gliomas: diffusional kurtosis imaging analysis of microstructural differences.

Authors:  Peter Raab; Elke Hattingen; Kea Franz; Friedhelm E Zanella; Heinrich Lanfermann
Journal:  Radiology       Date:  2010-01-20       Impact factor: 11.105

7.  Evaluation of histopathological changes in the microstructure at the center and periphery of glioma tumors using diffusional kurtosis imaging.

Authors:  Fuyan Li; Wenqi Shi; Dawei Wang; Yanjie Xu; Hongxia Li; Jingzhen He; Qingshi Zeng
Journal:  Clin Neurol Neurosurg       Date:  2016-10-27       Impact factor: 1.876

8.  Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps.

Authors:  Kyrre E Emblem; Baard Nedregaard; Terje Nome; Paulina Due-Tonnessen; John K Hald; David Scheie; Olivera Casar Borota; Milada Cvancarova; Atle Bjornerud
Journal:  Radiology       Date:  2008-06       Impact factor: 11.105

9.  Inter-rater agreement in glioma segmentations on longitudinal MRI.

Authors:  M Visser; D M J Müller; R J M van Duijn; M Smits; N Verburg; E J Hendriks; R J A Nabuurs; J C J Bot; R S Eijgelaar; M Witte; M B van Herk; F Barkhof; P C de Witt Hamer; J C de Munck
Journal:  Neuroimage Clin       Date:  2019-02-22       Impact factor: 4.881

10.  Multi-modal glioblastoma segmentation: man versus machine.

Authors:  Nicole Porz; Stefan Bauer; Alessia Pica; Philippe Schucht; Jürgen Beck; Rajeev Kumar Verma; Johannes Slotboom; Mauricio Reyes; Roland Wiest
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

View more
  1 in total

1.  Aberrant brain gray matter and functional networks topology in end stage renal disease patients undergoing maintenance hemodialysis with cognitive impairment.

Authors:  Jiahui Zheng; Xiangxiang Wu; Jiankun Dai; Changjie Pan; Haifeng Shi; Tongqiang Liu; Zhuqing Jiao
Journal:  Front Neurosci       Date:  2022-08-10       Impact factor: 5.152

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.